Total Payments
$51,880
2024 Payments
$211.40
Companies
35
Transactions
406
Medicare Patients
2,713
Medicare Billing
$179,865
Payment Breakdown by Category
Other$39,160 (75.5%)
Food & Beverage$7,721 (14.9%)
Travel$4,979 (9.6%)
Education$21.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,560 | 22 | 74.3% |
| Food and Beverage | $7,721 | 359 | 14.9% |
| Travel and Lodging | $4,979 | 20 | 9.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $600.00 | 1 | 1.2% |
| Education | $21.02 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $34,368 | 125 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $12,536 | 44 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $732.71 | 43 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $727.01 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $709.70 | 31 | $0 (2022) |
| Insmed, Inc. | $549.33 | 19 | $0 (2024) |
| Grifols USA, LLC | $439.97 | 23 | $0 (2022) |
| Inspire Medical Systems, Inc. | $225.07 | 2 | $0 (2024) |
| GENZYME CORPORATION | $169.30 | 9 | $0 (2022) |
| Abbott Laboratories | $158.46 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $211.40 | 6 | Inspire Medical Systems, Inc. ($105.15) |
| 2023 | $209.33 | 8 | Abbott Laboratories ($86.40) |
| 2022 | $771.70 | 35 | GlaxoSmithKline, LLC. ($129.94) |
| 2021 | $6,610 | 38 | GlaxoSmithKline, LLC. ($6,075) |
| 2020 | $8,875 | 40 | GlaxoSmithKline, LLC. ($8,231) |
| 2019 | $20,361 | 75 | GlaxoSmithKline, LLC. ($19,356) |
| 2018 | $1,431 | 97 | AstraZeneca Pharmaceuticals LP ($298.97) |
| 2017 | $13,412 | 107 | Sunovion Pharmaceuticals Inc. ($12,477) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/20/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $105.15 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 08/08/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 07/02/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROLOGY | ||||||
| 04/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $42.83 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/25/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diabetes Care | ||||||
| 06/25/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes Care | ||||||
| 06/01/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes Care | ||||||
| 04/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $65.66 | General |
| Category: INSOMNIA | ||||||
| 02/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes Care | ||||||
| 02/08/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Immunology | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Respiratory | ||||||
| 11/16/2022 | Teva Pharmaceuticals USA, Inc. | — | Food and Beverage | In-kind items and services | $13.05 | General |
| 11/15/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
| 09/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 615 | 686 | $274,323 | $40,915 |
| 2022 | 11 | 659 | 758 | $258,052 | $45,741 |
| 2021 | 11 | 665 | 784 | $250,838 | $49,755 |
| 2020 | 11 | 774 | 888 | $264,365 | $43,454 |
Total Patients
2,713
Total Services
3,116
Medicare Billing
$179,865
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 106 | 138 | $58,814 | $13,316 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 159 | 172 | $46,232 | $11,139 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 55 | 55 | $33,021 | $6,712 | 20.3% |
| 94660 | Therapy procedure using a positive pressure ventilator | Facility | 2023 | 176 | 200 | $55,146 | $4,910 | 8.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 30 | 31 | $41,323 | $2,676 | 6.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 11 | 11 | $16,544 | $926.20 | 5.6% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 26 | 26 | $8,008 | $707.49 | 8.8% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 14 | 15 | $7,350 | $233.94 | 3.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 12 | 12 | $2,412 | $108.12 | 4.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 13 | 13 | $2,951 | $100.10 | 3.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 13 | 13 | $2,522 | $86.32 | 3.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 97 | 133 | $53,048 | $13,990 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 174 | 207 | $51,909 | $13,717 | 26.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 65 | 65 | $36,646 | $7,684 | 21.0% |
| 94660 | Therapy procedure using a positive pressure ventilator | Facility | 2022 | 184 | 214 | $55,206 | $5,742 | 10.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 27 | 27 | $33,642 | $2,388 | 7.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 14 | 14 | $1,822 | $817.88 | 44.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 21 | 21 | $6,048 | $649.93 | 10.7% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 18 | 18 | $8,244 | $308.14 | 3.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 22 | 22 | $4,664 | $165.44 | 3.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 18 | 18 | $3,384 | $156.85 | 4.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 19 | 19 | $3,439 | $122.24 | 3.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 198 | 243 | $57,538 | $17,149 | 29.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 83 | 117 | $44,141 | $12,393 | 28.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 61 | 61 | $32,504 | $7,973 | 24.5% |
About Dr. Michael Katzoff, MD
Dr. Michael Katzoff, MD is a Pulmonary Disease healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558304485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Katzoff, MD has received a total of $51,880 in payments from pharmaceutical and medical device companies, with $211.40 received in 2024. These payments were reported across 406 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,560).
As a Medicare-enrolled provider, Katzoff has provided services to 2,713 Medicare beneficiaries, totaling 3,116 services with total Medicare billing of $179,865. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Milwaukee, WI
- Active Since 06/14/2006
- Last Updated 02/01/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1558304485
Products in Payments
- TRELEGY ELLIPTA (Drug) $25,682
- UTIBRON (Drug) $12,467
- ANORO (Drug) $7,737
- Arikayce (Drug) $549.33
- XYREM (Drug) $292.19
- STIOLTO RESPIMAT (Drug) $281.24
- Prolastin-C Liquid (Biological) $274.19
- NUCALA (Biological) $259.12
- DUPIXENT (Biological) $243.17
- SYMBICORT (Drug) $210.09
- BEVESPI AEROSPHERE (Drug) $202.50
- SUNOSI (Drug) $194.57
- Prolastin-C (Biological) $165.78
- STIOLTO (Drug) $156.07
- SMARTVEST (Device) $143.81
- Xyrem (Drug) $142.71
- Inspire Upper Airway Stimulation System (Device) $119.92
- FASENRA (Drug) $114.70
- INSPIRE (Device) $105.15
- Yupelri (Drug) $101.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Milwaukee
Mouhammed Rihawi, Md, MD
Pulmonary Disease — Payments: $841,621
Pulmonary Disease $841,621
Ali Musani, Md, MD
Pulmonary Disease — Payments: $82,051
Pulmonary Disease $82,051
Steven Leh, Md, MD
Pulmonary Disease — Payments: $24,153
Pulmonary Disease $24,153
Dr. Uzair Ghori, M.d, M.D
Pulmonary Disease — Payments: $18,539
Pulmonary Disease $18,539
Huzaifah Salat, M.d, M.D
Pulmonary Disease — Payments: $9,968
Pulmonary Disease $9,968
Dr. Kavita Ratarasarn, Md, MD
Pulmonary Disease — Payments: $9,568
Pulmonary Disease $9,568